Jesutosin Omowumi Babalola

Ms. Jesutosin Omowumi Babalola

Biochemistry, University of Ibadan, Ibadan, Oyo, Nigeria

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2025 in Toxics
Verified
Journal Article
Open access
PDF file
Solomon OwumiSolomon Owumi
Solomon Owumi
MOMoses Otunla
Moses Otunla
PAPelumi Akindipe
Pelumi Akindipe
Uche Okuu ArunsiUche Okuu Arunsi
Uche Okuu Arunsi
Jesutosin Omowumi BabalolaJesutosin Omowumi Babalola
Jesutosin Omowumi Babalola
Adegboyega OyelereAdegboyega Oyelere
Adegboyega Oyelere
Mercury exposure has been linked to male infertility. Given that mercury chloride (HgCl2) may promote an oxido-inflammatory milieu associated with pathophysiological derangements, it is hypothesised that Thymoquinone (TQ), an antioxidant and anti-inflammatory agent, may mitigate the gradual harmful effects of mercury exposure on rat testes, epididymis, and hypothalamus, as these organs are vital to reproductive function. To test this hypothesis, 40 rats (strain: Wistar; sex: male) were randomly assigned to five cohorts of eight rats each. After a 7-day acclimation, treatments were dispensed for 28 consecutive days accordingly: Cohort I: distilled water only, as control; Cohort II: HgCl2 only (20 µg/mL); Cohort III: TQ only (2.5 mg/kg); Cohort IV: HgCl2 + TQ (20 µg/mL + 2.5 mg/kg); and Cohort V: HgCl2 + TQ (20 µg/mL + 5 mg/kg). Co-treatment with TQ preserved the body and organ weight of the HgCl2 exposed animals. However, TQ did not reduce HgCl2-induced dysfunction in sperm function and morphology. The serum follicle-stimulating hormone (FSH), luteinising hormone (LH), and testosterone were increased significantly (p < 0.05) by TQ co-treatment, while decreasing the prolactin level. TQ administration also increased (p < 0.05) testicular enzymes, including alkaline phosphatase (ALP), lactate dehydrogenase (LDH), acid phosphatase (ACP), and glucose-6-phosphate dehydrogenase (G6PD) activities, which HgCl2 decreased. TQ administration increased (p < 0.05) HgCl2-induced decreases in catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione (GSH), glutathione-s-transferase (GST), and total sulfhydryl group (TSH) levels in the testes, epididymis, and hypothalamus of experimental rats. Further, TQ reduced HgCl2-mediated increases in RONS-reactive oxygen and nitrogen species; LPO–lipid peroxidation; PC–protein carbonyl formation; and XO–xanthine oxidase activity. Furthermore, levels of inflammatory biomarkers, including tumour necrosis factor alpha (TNF-α), nitric oxide (NO), interleukin-1 beta (IL-1β), and myeloperoxidase (MPO), were decreased (p < 0.05) in the co-treated groups, with a higher dose of TQ (5.0 mg/kg) showing a more pronounced protective effect. Additionally, TQ co-administration increased Bax and decreased Bcl-2 and p53 protein levels (p < 0.05), thereby protecting the rats’ testes, epididymis, and hypothalamus from HgCl2-induced apoptosis. Molecular docking simulation analysis revealed TQ interaction dynamics with PPAR-α and PPAR-δ to suppress NF-kB-mediated pro-inflammatory sequela as well as activate Nrf-2-mediated antioxidant defence system. These predicted biological effects of TQ resonate with the findings from the in vivo studies. Therefore, supplementation with TQ may help reduce chemical-induced toxicities, including HgCl2‘s reproductive toxicity.

18 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Solomon OwumiSolomon Owumi
Solomon Owumi
MOMoses Otunla
Moses Otunla
PAPelumi Akindipe
Pelumi Akindipe
Uche Okuu ArunsiUche Okuu Arunsi
Uche Okuu Arunsi
Jesutosin Omowumi BabalolaJesutosin Omowumi Babalola
Jesutosin Omowumi Babalola
Adegboyega OyelereAdegboyega Oyelere
Adegboyega Oyelere
Mercury exposure has been linked to male infertility. Given that mercury chloride (HgCl2) may promote an oxido-inflammatory milieu associated with pathophysiological derangements, it is hypothesised that thymoquinone (TQ), an anti oxido-inflammatory agent, may mitigate the gradual harmful effects of mercury exposure on rat testes, epididymis, and hypothalamus, as these organs are vital to reproductive function. To test this hypothesis, 40 male Wistar rats were randomised into five groups (n=8). After a 7-day acclimation, treatments were dispensed for 28 days as follows: Group I: control (distilled water only); Group II: HgCl2 only (20 µg/mL); Group III: TQ only (2.5 mg/kg); Group IV: HgCl2 + TQ (20 µg/mL + 2.5 mg/kg); and Group V: HgCl2 + TQ (20 µg/mL + 5 mg/kg). Co-treatment with TQ preserved the body and organ weight of the HgCl2­-exposed animals. However, TQ did not reduce HgCl2-induced dysfunction in sperm function and morphology. Co-treatment with TQ significantly (p< 0.05) increased the serum levels of follicle-stimulating hormone (FSH), luteinising hormone (LH), and testosterone while decreasing the prolactin level. TQ administration also increased (p< 0.05) the activity of testicular enzymes alkaline phosphatase (ALP), acid phosphatase (ACP), lactate dehydrogenase (LDH), and glucose-6-phosphate dehydrogenase (G6PD), decreased by HgCl2. TQ administration significantly (p< 0.05) restored HgCl2-induced decreases in superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione-s-transferase (GST), glutathione (GSH), and total sulfhydryl groups (TSH) levels in the testes, epididymis, and hypothalamus of experimental rats. Further, TQ reduced HgCl2-mediated increases in reactive oxygen and nitrogen species (RONS), lipid peroxidation (LPO), protein carbonyl (PC), and xanthine oxidase (XO) activity. Furthermore, levels of inflammatory biomarkers including nitric oxide (NO), tumor necrotic factor alpha (TNF-), interleukin-1 beta (IL-1), and myeloperoxidase (MPO) were significantly (p< 0.05) decreased in the co-treated groups, with a higher dose of TQ (5.0 mg/kg) showing a more pronounced protective effect. Additionally, TQ co-administration increased Bax and decreased Bcl-2 and P53 protein levels (p< 0.05), protecting rats' testes, epididymis, and hypothalamus from HgCl2-induced apoptosis. Molecular docking simulation studies showed that TQ may interact with PPAR-α and PPAR- to suppress NF-kB-mediated pro-inflammatory sequela as well as activate Nrf-2-mediated antioxidant defence system. These predicted biological effects of TQ resonate with the findings from the in vivo studies. Therefore, supplementation with TQ may help reduce chemical-induced toxicities, including HgCl2‘s reproductive toxicity.

18 February 2026 in Toxics
Verified
Journal Article
Open access
PDF file
Solomon OwumiSolomon Owumi
Solomon Owumi
EPEsther Mayowa Pius
Esther Mayowa Pius
HAHikmah Adeola Abdulganiyu
Hikmah Adeola Abdulganiyu
IAIFEOLUWA OLUWAJENYO ALABI
IFEOLUWA OLUWAJENYO ALABI
VEVictor Oladimeji Eso
Victor Oladimeji Eso
CAChima M. Amadi
Chima M. Amadi
Benign prostatic hyperplasia (BPH) is a significant health issue among ageing men, with ongoing research focused on elucidating its underlying mechanisms and improving experimental models. Testosterone Propionate (TP) is the first line of choice for the induction of BPH in experimental rodent models. However, TP’s controlled status as a Schedule III drug in the United States and a Class C drug in the UK presents challenges in obtaining TP for experimental use, giving preference to the sulpiride model since it is easily obtained as an alternative for the induction and study of BPH. A comprehensive literature search was conducted across multiple electronic databases, including PubMed/MEDLINE, Embase, and Web of Science. The primary PubMed search strategy included combinations of Medical Subject Headings (MeSH) and free-text terms: (“Benign prostatic hyperplasia induction” OR “and rodent models’’) AND (“Testosterone Propionate model”) AND (“sulpiride model”). Studies were included if they induced BPH (using testosterone or sulpiride models). Titles and abstracts were screened for relevance; eligible articles underwent full-text review, with data extracted thematically. No formal risk-of-bias scoring was used due to the narrative approach; instead, studies were appraised by design, rigor, plausibility, and evidence. This study reviewed published and publicly available data, so no ethical approval was required. Although both TP and sulpiride induce BPH via various mechanisms, this review provides a comparative analysis of these two commonly utilised models for studying BPH. In the TP approach, castrated rodents receive daily subcutaneous injections for 4 weeks, resulting in dihydrotestosterone (DHT)-mediated epithelial hyperplasia predominantly affecting the ventral prostate lobes. Conversely, the sulpiride model is non-invasive, employs intact animals treated with sulpiride, and induces hyperprolactinemia-mediated BPH via interactions with androgen and oestrogen receptor pathways that stimulate prostatic stromal and epithelial proliferation, particularly in the lateral and dorsal lobes, representing an alternative method. We also highlight the strengths and limitations of TP and sulpiride in replicating clinical symptoms and examine the toxicological effects of sulpiride on the kidney, testis, liver, and brain. We recommend the sulpiride model for the induction and studying of BPH, as it is readily accessible and closely mimics the pathogenesis of BPH in humans, unlike the TP model, which requires castration.
1

7 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Solomon OwumiSolomon Owumi
Solomon Owumi
EPEsther Mayowa Pius
Esther Mayowa Pius
HAHikmah Adeola Abdulganiyu
Hikmah Adeola Abdulganiyu
IAIFEOLUWA OLUWAJENYO ALABI
IFEOLUWA OLUWAJENYO ALABI
VEVictor Oladimeji Eso
Victor Oladimeji Eso
CAChima M. Amadi
Chima M. Amadi
Background: Benign prostatic hyperplasia (BPH) is a significant health issue among ageing men, with ongoing research focused on elucidating its underlying mechanisms and improving experimental models. Testosterone Propionate (TP) is the first line of choice for the induction of BPH in experimental rodent models. However, TP's controlled status as a Schedule III drug in the United States and a Class C drug in the UK presents challenges in obtaining TP for experimental use, giving preference to the sulpiride model since it is easily obtained as an alternative for the induction and study of BPH. Method: A comprehensive literature search was conducted across multiple electronic databases, including PubMed/MEDLINE, Embase, and Web of Science. The primary PubMed search strategy included combinations of Medical Subject Headings (MeSH) and free-text terms: (“Benign prostatic hyperplasia induction” OR ‘’ and rodent models’’) AND (“Testosterone Propionate model” ) AND (“sulpiride model”). Studies were included if they induced BPH (using testosterone or sulpiride models). Titles and abstracts were screened for relevance; eligible articles underwent full-text review, with data extracted thematically. No formal risk-of-bias scoring was used due to the narrative approach; instead, studies were appraised by design, rigor, plausibility, and evidence. This study reviewed published and publicly available data, so no ethical approval was required. Results: Although both TP and sulpiride induce BPH via various mechanisms, this review provides a comparative analysis of these two commonly utilised models for studying BPH. In the TP approach, castrated rodents receive daily subcutaneous injections for 4 weeks, resulting in dihydrotestosterone (DHT)-mediated epithelial hyperplasia predominantly affecting the ventral prostate lobes. Conversely, the sulpiride model is non-invasive, employs intact animals treated with sulpiride, and induces hyperprolactinemia-mediated BPH via interactions with androgen and oestrogen receptor pathways that stimulate prostatic stromal and epithelial proliferation, particularly in the lateral and dorsal lobes, representing an alternative method. We also highlight the strengths and limitations of TP and sulpiride in replicating clinical symptoms and examine the toxicological effects of sulpiride on the kidney, testis, liver, and brain. Conclusions: we recommend the sulpiride model for the induction and studying of BPH, as it is readily accessible and closely mimics the pathogenesis of BPH in humans, unlike the TP model, which requires castration.